As Senior Director of Data Science at Propensity4, Isabelle leads the integration of advanced modeling and AI-driven insights into the company’s analytics and forecast offerings. Combining over a decade of pharmaceutical experience with advanced fluency in data science, machine learning, generative AI, and real-world healthcare data, she offers a rare end-to-end perspective bridging scientific rigor with real-world commercial application. She works closely with commercial, marketing, and patient solutions teams to turn complex healthcare data into clear, actionable strategies.
Isabelle’s career has evolved from pharmaceutical bench research to cutting-edge data science. After earning her Ph.D. in Pharmaceutical Sciences, she shifted from the lab to analytics, leveraging an M.S. in Data Science to build predictive models that shaped payer strategy, patient engagement, and drug-development pipelines. She has since expanded her portfolio to include generative-AI solutions for health applications and is excited to bring this expertise to Propensity4. Joining the organization is the next step in her journey to deliver scalable, production-ready analytics and AI solutions for complex commercial challenges.
Isabelle’s mission is personal. Inspired by her mother’s nine-year battle with glioblastoma, she is driven to ensure that more patients reach the right treatment at the right time. At work, she’s passionate about demystifying data and mentoring the next generation of data scientists, always keeping patient impact at the forefront.
Outside of work, Isabelle enjoys spending time with her husband, son, dog, and two cats. She also enjoys taking dance classes and traveling the world.
“Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less.”
— Marie Curie